일개 농촌 인구 집단에서 고혈압과 비만이 심초음파로 측정한 좌심실비대 및 미세단백뇨에 미치는 영향
Association of Hypertension and Obesity with Echocardiographic Left Ventricular Hypertrophy or Microalbuminuria in a General Population in South Korea
1
조회
0
다운로드
0
인용
0
참고문헌
초록
Background: Both left ventricular hypertrophy (LVH) and microalbuminuria (MA) are well described markers or surrogate for cardiovascular outcome. Many factors are known to be related to the two markers which are encountered together in some patients. But the epidemiological backgrounds for the two markers are not clearly demonstrated so far. Methods:Measurements of echocardiographic left ventricular mass index (LVMI) and MA were introduced to the population survey in Yangpyeong County, Korea in 2005 and 2006 for 1,767 among 2,028 subjects. The criteria for MA were 17-250 mg/g of albumin creatinine ratio (ACR) in male and 25-355 mg/g in female. 1,636 data were analyzed. Results: Age was 60.9 ± 10.4years and the proportion of female was 59.4% (972). Body mass index (BMI) was 24.7 ± 3.21 kg/m^2 and blood pressure were 124.1 ± 17.3 mm Hg/80.0 ± 10.5 mm Hg. LVMI was 45.3 ± 11.6 g/m2.7 and ACR was 23.9 ± 150.9 mg/g. Prevalence of LVH and MA were 23.5% and 12.2%, respectively. In male/female, odds ratios for MA were 1.035 (range, 1.010-1.061)/1.01(range, 0.988-1.032) for age, 0.962 (range, 0.882-1.049)/0.941 (range, 0.881-1.006) for BMI, 1.754 (range, 1.097-2.804)/2.158 (range, 1.413-3.298) for hypertension (HTN), 4.87 (range, 2.883-8.226)/2.154 (range, 1.311-3.539) for diabetes, 1.005(range, 0.999-1.012)/1.007 (range, 1.002-1.012) for cholesterol, and 1.011 (range, 0.987-1.035)/1.011 (range, 0.994-1.029)for LVH. Conclusions: In a population level, even if diabetes was strongest factor for MA, HTN is also independent factor for MA in both genders.
Abstract
Background: Both left ventricular hypertrophy (LVH) and microalbuminuria (MA) are well described markers or surrogate for cardiovascular outcome. Many factors are known to be related to the two markers which are encountered together in some patients. But the epidemiological backgrounds for the two markers are not clearly demonstrated so far. Methods:Measurements of echocardiographic left ventricular mass index (LVMI) and MA were introduced to the population survey in Yangpyeong County, Korea in 2005 and 2006 for 1,767 among 2,028 subjects. The criteria for MA were 17-250 mg/g of albumin creatinine ratio (ACR) in male and 25-355 mg/g in female. 1,636 data were analyzed. Results: Age was 60.9 ± 10.4years and the proportion of female was 59.4% (972). Body mass index (BMI) was 24.7 ± 3.21 kg/m^2 and blood pressure were 124.1 ± 17.3 mm Hg/80.0 ± 10.5 mm Hg. LVMI was 45.3 ± 11.6 g/m2.7 and ACR was 23.9 ± 150.9 mg/g. Prevalence of LVH and MA were 23.5% and 12.2%, respectively. In male/female, odds ratios for MA were 1.035 (range, 1.010-1.061)/1.01(range, 0.988-1.032) for age, 0.962 (range, 0.882-1.049)/0.941 (range, 0.881-1.006) for BMI, 1.754 (range, 1.097-2.804)/2.158 (range, 1.413-3.298) for hypertension (HTN), 4.87 (range, 2.883-8.226)/2.154 (range, 1.311-3.539) for diabetes, 1.005(range, 0.999-1.012)/1.007 (range, 1.002-1.012) for cholesterol, and 1.011 (range, 0.987-1.035)/1.011 (range, 0.994-1.029)for LVH. Conclusions: In a population level, even if diabetes was strongest factor for MA, HTN is also independent factor for MA in both genders.
참고문헌 (26)
- [URL]
- Kannel WB, "Comparison of risk profiles for cardiovascular events: implications for prevention", Advances in Internal Medicine, 42, pp.39~66 (1997)
- Rodrigues SL, "Determinants of left ventricular mass and presence of metabolic risk factors in normotensive individuals", International Journal of Cardiology, 135, pp.323~330 (2009)
- Levy D, "Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study", Annals of Internal Medicine, 108, pp.7~13 (1988)
- Gosse P, "Left ventricular hypertrophy: epidemiological prognosis and associated critical factors", European Heart Journal, 14(D), pp.16~21 (1993)
- Gardin JM, "M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study)", American Journal of Cardiology, 87, pp.1051~1057 (2001)
- Casale PN, "Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men", Annals of Internal Medicine, 105, pp.173~178 (1986)
- Levy D, "Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study", The New England Journal of Medicine, 322, pp.1561~1566 (1990)
- Barzilay JI, "The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: the cardiovascular health study", American Journal of Kidney Diseases, 44, pp.25~34 (2004)
- Mulyadi L, "Body fat distribution and total body fat as risk factors for microalbuminuria in the obese", Annals of Nutrition and Metabolism, 45, pp.67~71 (2001)
- Kim SJ, "The relation of circadian blood pressure variation to left ventricular mass, diastolic function and QT interval", Journal of the Korean Society of Hypertension, 9, pp.49~56 (2003)
- Sahn DJ, "Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements", Circulation, 58, pp.1072~1083 (1978)
- Devereux RB, "Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings", American Journal of Cardiology, 57, pp.450~458 (1986)
- de Simone G, "Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk", Journal of the American College of Cardiology, 25, pp.1056~1062 (1995)
- Shin J, "Influence of abdominal circumference on the inappropriateness of left ventricular mass and diastolic function in non-obese patients", American Journal of Cardiology, 49, pp.323~329 (2007)
- Warram JH, "Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin", creatinine ratio, 1996, pp.7, 930~937
- Lieb W, "Association of low-grade urinary albumin excretion with left ventricular hypertrophy in the general population: the MONICA", KORA Augsburg Echocardiographic Substudy, 2006, pp.21, 2780~2787
- Fox ER, "Left ventricular geometric patterns in the Jackson cohort of the Atherosclerotic Risk in Communities (ARIC) Study: clinical correlates and influences on systolic and diastolic dysfunction", American Heart Journal, 153, pp.238~244 (2007)
- Song Y, "Relation between microalbuminuria and estimated glomerular filtration rate by creatinine and cystatin C", Journal of Laboratory Medicine and Quality Assurance, 30, pp.259~265 (2008)
- Agewall S, "Risk factors that predict development of microalbuminuria in treated hypertensive men. The Risk Factor Intervention Study Group", Angiology, 47, pp.963~972 (1996)
- Campos-Pastor MM, "Factors associated with microalbuminuria in type 1 diabetes mellitus: a cross-sectional study", Diabetes Research and Clinical Practice, 48, pp.43~49 (2000)
- Cederholm J, "Steering Committee of the Swedish National Diabetes Register. Microalbuminuria and risk factors in type 1 and type 2 diabetic patients", Diabetes Research and Clinical Practice, 67, pp.258~266 (2005)
- Jensen JS, "Atherosclerotic risk factors are increased in clinically healthy subjects with microalbuminuria", Atherosclerosis, 112, pp.245~252 (1995)
- Kim CH, "Association of microalbuminuria and atherosclerotic risk factors in non-diabetic subjects in Korea", Diabetes Research and Clinical Practice, 40, pp.191~199 (1998)
- Lauer MS, "The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study", JAMA, 266, pp.231~236 (1991)
- Ferrara AL, "Is there a relationship between left ventricular mass and plasma glucose and lipids independent of body mass index? Results of the Gubbio Study", Nutrition, Metabolism & Cardiovascular Diseases, 13, pp.126~132 (2003)